MCRB icon

Seres Therapeutics
MCRB

Overview Fund Activity

113 hedge funds and large institutions have $2.42B invested in Seres Therapeutics in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
+20
Holders Change %
+21.51%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
37
Increased
40
Reduced
30
Closed
17
Calls
$83.3M
Puts
$19.3M
Net Calls
+$63.9M
Net Calls Change
+$63.9M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$303M
2
RCM
2
RA Capital Management
Massachusetts
$134M
3
GGHC
3
Gilder Gagnon Howe & Co
New York
$90.2M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$54.2M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$79M

Top Sellers

1
Sumitomo Mitsui Trust Group
1
Sumitomo Mitsui Trust Group
Japan
$157M
2
NAMA
2
Nikko Asset Management Americas
New York
$152M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$10.7M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$5.04M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$14.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
126
Aries Wealth Management
Maine
– -$48K -500 Closed
CAN
127
Cetera Advisor Networks
California
– -$14K -150 Closed
PAG
128
Private Advisor Group
New Jersey
– -$13K -140 Closed
PHK
129
Point72 Hong Kong
Hong Kong
– -$3K -28 Closed
SF
130
Synovus Financial
Georgia
– -$2K -25 Closed
2 3 4 5
6